Artimplant Nine Month Interim Report Conference Call, November 10, 2005

Report this content

CEO Tord Lendau and VP, Medical Affairs Elisabeth Liljensten presents the Interim Report for the period January – September 2005.

The presentation will be in English Date: Thursday, November 10 Time: 10.00 a .m. CET Dial in Number: +44 (0)20 7365 1839 A live broadcast of the telephone conference will available on Artimplant´s website www.artimplant.com For additional information, please contact: Tord Lendau, CEO, phone +46 (0)31 746 56 00, +46 (0)708 369 403, tord.lendau@artimplant.se Web site: www.artimplant.com Artimplant has also posted the following press releases the last four months on www.artimplant.com Artimplant and ArthroCare Corporation sign distribution agreement for North America Artelon® nanofibers successfully used as coating on metal implants Artimplant signs four new development and license agreements with Small Bone Innovations Artimplant receives CE-mark for Artelon® Surgical Suture Artimplant expands its long-term degradable Artelon® Surgical Suture product range New study shows that Artelon® works as a dermal filler Artimplant expand the field of application for Artelon® Artimplant employs Ms. Susanne Hamilton as Product Manager Odontology Artimplant appoints Lars-Johan Cederbrant as Chief financial Officer Electrospinning of Artelon® in collaboration with IFP Research and Chalmers University of Technology expand the opportunities for Artimplant Artimplant boosts its commercial base through CE-mark for two new products within odontology and craniomaxillofacial surgery

Documents & Links